7Baggers
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 
      
                              
      revenues
    36,289,000 38,514,000 37,093,000 38,812,000 49,667,000 47,052,000 41,189,000 42,814,000 68,736,000 59,628,000 50,603,000 43,991,000 61,008,000 46,754,000 33,424,000 31,863,277 9,476,956 7,827,718 5,723,049 5,318,905 11,602,722 11,096,016 5,012,713 11,984,967 10,195,968  
      cost of revenues
    24,037,000 23,986,000 24,278,000 26,500,000 31,653,000 29,224,000 26,041,000 28,416,000 47,716,000 42,794,000 37,987,000 34,650,000 45,210,000 33,920,000 24,872,000 28,301,390 7,452,453 5,137,168 4,131,989 4,648,864 8,163,811 7,847,790 3,428,173 8,970,438 7,763,617  
      gross profit
    12,252,000 14,528,000 12,815,000 12,312,000 18,014,000 17,828,000 15,148,000 14,398,000 21,020,000 16,834,000 12,616,000 9,341,000 15,798,000 12,834,000 8,552,000 3,561,887 2,024,503 2,690,550 1,591,060 670,041 3,438,911 3,248,226 1,584,540 3,014,529 2,432,351  
      yoy
    -31.99% -18.51% -15.40% -14.49% -14.30% 5.90% 20.07% 54.14% 33.05% 31.17% 47.52% 162.25% 680.34% 377.00% 437.50% 431.59% -41.13% -17.17% 0.41% -77.77% 41.38%      
      qoq
    -15.67% 13.37% 4.09% -31.65% 1.04% 17.69% 5.21% -31.50% 24.87% 33.43% 35.06% -40.87% 23.09% 50.07% 140.10% 75.94% -24.76% 69.10% 137.46% -80.52% 5.87% 104.99% -47.44% 23.93%   
      gross margin %
                              
      operating expense:
                              
      general and administrative
    12,089,000 12,321,000 15,249,000 11,341,500 15,408,000 15,227,000 14,731,000                 2,795,826.25 4,262,707  
      research and development
    1,022,000 985,000 1,171,000 1,054,000 979,000 525,000 597,000 617,000 604,000 649,000 613,000 516,000 355,000 481,000 474,000 345,905 471,129 285,210 316,756 317,798 351,104 324,582 235,996 303,098 98,952  
      impairment of goodwill
       11,969,000 13,226,000                      
      total operating expense
    13,111,000 13,306,000 16,420,000 28,909,000 29,613,000 15,752,000 15,328,000 15,240,000 14,556,000 15,953,000 16,070,000 14,942,000 12,288,000 11,281,000 10,586,000 11,058,845 3,777,974 3,484,695 4,254,485 4,176,553 4,609,270 4,218,736 3,996,108 4,097,872 4,361,659  
      income from operations
    -859,000 1,222,000 -3,605,000 -16,597,000 -11,599,000 2,076,000 -180,000 -842,000 6,464,000 881,000 -3,454,000 -5,601,000 3,510,000 1,553,000 -2,034,000 -7,496,958 -1,753,471 -794,146 -2,663,425 -3,506,512 -1,170,359 -970,510 -2,411,568 -1,083,343 -1,929,308  
      yoy
    -92.59% -41.14% 1902.78% 1871.14% -279.44% 135.64% -94.79% -84.97% 84.16% -43.27% 69.81% -25.29% -300.17% -295.56% -23.63% 113.80% 49.82% -18.17% 10.44% 223.68% -39.34%      
      qoq
    -170.29% -133.90% -78.28% 43.09% -658.72% -1253.33% -78.62% -113.03% 633.71% -125.51% -38.33% -259.57% 126.01% -176.35% -72.87% 327.55% 120.80% -70.18% -24.04% 199.61% 20.59% -59.76% 122.60% -43.85%   
      operating margin %
                              
      other income:
                              
      interest expense
    -2,550,000 -2,566,000 -2,607,000 -2,618,000 -2,987,000 -2,788,000 -2,447,000 -2,593,000 -2,598,000 -2,417,000 -2,317,000 -730,000 -870,000 -764,000 -1,018,000 -1,196,634 -530,830 -628,216 -459,320 -516,594 -517,391 -479,022  -299,132 -188,457  
      other income
    330,000 -229,000 -199,000 -186,000 -181,000 -28,000 -22,000 -63,000 -128,000 -60,000 -15,000 -74,000 34,000 5,000 15,000 68,068 -14,673 17,655 57,950 21,718 21,077 23,670 21,209 26,042 38,796  
      change in fair value of derivative liabilities
    6,000 4,000 192,000 217,000 90,000  -224,000        -265,000        -2,162,495    
      total other income
    -2,214,000 -2,791,000 -2,614,000 -2,587,000 -3,078,000 -2,632,000 -2,693,000 -1,602,000 -2,839,000 -814,000 -1,488,000 -2,167,000 -1,390,000 -1,251,000 -3,114,000 -1,889,519 -2,457,433 -631,850 713,802 248,555 875,863 -192,092 -2,275,455 488,881 707,947  
      income before income taxes
    -3,073,000 -1,569,000 -6,219,000 -19,184,000 -14,677,000 -556,000 -2,873,000 -312,500 3,625,000 67,000 -4,942,000 -681,000 2,120,000 302,000             
      income tax benefit
    12,000 91,000    -255,000 -51,000   -41,000 86,000                
      net income
    -3,061,000 -1,478,000 -7,089,000 -17,671,000 -17,750,000 -811,000 -2,924,000 -431,250 3,105,000 26,000 -4,856,000 -1,665,000 729,000 -2,220,000 -5,169,000 -8,565,477 -4,210,904 -1,425,996 -1,949,623 -3,257,957 -294,496 -1,162,602 -4,687,023 -594,462 -1,221,361  
      yoy
    -82.75% 82.24% 142.44% 3997.62% -671.66% -3219.23% -39.79% -74.10% 325.93% -101.17% -6.06% -80.56% -117.31% 55.68% 165.13% 162.91% 1329.87% 22.66% -58.40% 448.05% -75.89%      
      qoq
    107.10% -79.15% -59.88% -0.45% 2088.66% -72.26% 578.03% -113.89% 11842.31% -100.54% 191.65% -328.40% -132.84% -57.05% -39.65% 103.41% 195.30% -26.86% -40.16% 1006.28% -74.67% -75.20% 688.45% -51.33%   
      net income margin %
                              
      fixed dividends - series b preferred
    -317,000 -317,000 -317,000 -317,000 -317,000 -317,000 -317,000 -238,000 -317,000 -317,000 -317,000 -238,000 -317,000 -317,000             
      net income attributable to common stockholders
    -3,378,000 -1,795,000 -7,406,000 -17,988,000 -18,067,000 -1,128,000 -3,241,000 -2,335,000 2,788,000 -291,000  -7,459,000 412,000 -2,170,000 -5,486,000            
      comprehensive loss:
                              
      other comprehensive loss:
                              
      foreign currency translation adjustment
    2,270,000 -47,000 -811,000 2,789,000 -2,854,000 1,722,000 558,000 6,807,000 -5,040,000 -4,637,000 -1,772,000    -261,000            
      total comprehensive loss
    -791,000  -7,900,000 -14,882,000 -20,604,000  -2,366,000 4,789,000 -1,935,000 -4,611,000 -6,628,000 -6,868,000 -1,279,000 -1,690,000 -5,430,000 -3,763,271 -3,674,786 -1,430,893 -2,053,050 -3,162,813 -306,059 -1,139,640 -4,725,170 -608,472 -1,240,236  
      net income per common share – basic and diluted
    -340 -180     -40   -70   -40 -90 -389.69 -0.1 -0.08 -0.16 -0.3 -0.03 -0.11     
      weighted-average number of common shares outstanding – basic and diluted
    9,823,000 9,787,000        65,820,000  58,849,000  57,871,000 55,150,000 42,198,000 44,214,758 17,637,458 12,493,829 10,689,408 10,746,186 10,590,451  9,922,042   
      total comprehensive income
     -1,525,000    911,000                     
      income tax expense
      -870,000 1,513,000 -3,073,000   -118,750 -520,000   -984,000 -1,391,000 -2,522,000 -21,000            
      net income per common share – basic and diluted, as adjusted
      -760   -120                     
      weighted-average number of common shares outstanding – basic and diluted, as adjusted
      9,714,000                        
      gain on settlement of liabilities
             3,000     -1,846,000            
      net income per common share – basic, as adjusted
       -597.5 -1,900                      
      net income per common share - diluted, as adjusted
       -597.5 -1,900                      
      weighted-average number of common shares outstanding – basic, as adjusted
        9,484,000                      
      weighted-average number of common shares outstanding – diluted, as adjusted
        9,484,000                      
      ​
                              
      comprehensive income:
                              
      other comprehensive income:
                              
      general and administrative expenses
           14,623,000 13,952,000 15,304,000 15,457,000 14,426,000 11,933,000 10,800,000 10,112,000 10,712,940 3,306,845 3,199,486 3,937,729 3,858,755 4,258,166 3,894,154 3,760,112    
      changes in fair value of derivative liabilities
           384,250 -113,000 1,660,000 -10,000 177,000 60,000 41,000  -59,835 -193,640 -74,363 28,663 -131,764.5 1,372,177 263,260  -83,747.5 821,528  
      deemed contribution -series b preferred
               91,750  367,000             
      net income per common share – basic
           -10 40   -30 10           -0.165 -0.12  
      net income per common share – diluted
           -10 30   -30 10           -0.165 -0.12  
      weighted-average number of common shares outstanding – basic
                60,094,000            10,095,889  
      weighted-average number of common shares outstanding – diluted
                64,710,000            10,095,889  
      (gain) loss on settlement of liabilities
              854,000                
      income from settlements of liabilities
               -748,000 -614,000              
      foreign currency translation gain
               274,000 -2,008,000 530,000  106,948.5 536,118 -4,897    22,962 -38,147    
      gain from settlements of liabilities
                 -533,000  -144,676.75 -1,718,290 53,074 1,086,509 36,608.5    41,344.5 36,080  
      net income before income taxes
                  -5,148,000            
      fixed dividends to series b preferred shareholders
                  317,000            
      foreign currency translation loss
                      -103,427 -6,687.25 -11,563   -14,010 -18,875  
      operating expense
                              
      interest (expense)
                          -280,603    
      gain on settlements of liabilities
                          146,434    
      other comprehensive loss
                              
      net income per common share - basic and diluted
                          -0.46    
      weighted-average number of common shares outstanding - basic and diluted
                          10,255,808    
      comprehensive gain:
                              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.